Bronchiectasis Therapeutic Market - Top Companies and Manufacturers

  • Report ID: 5679
  • Published Date: Feb 20, 2024
  • Report Format: PDF, PPT

Companies Dominating the Bronchiectasis Therapeutic Landscape

top-features-companies
    • GlaxoSmithKline Plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Reckitt and Benckiser Group Plc
    • Zydus Pharmaceuticals, Inc. 
    • Teva Pharmaceutical Industries Ltd.
    • Merck & Co., Inc.
    • Insmed Inc. 
    • Reddy’s Laboratories Ltd
    • Pfizer Inc.
    • Janssen Pharmaceuticals, Inc.
    • Boehringer Ingelheim International GmbH

Browse Key Market Insights with Data Illustration:

In the News

  • GlaxoSmithKline Pharmaceuticals released Trelegy Ellipta to patients with chronic obstructive pulmonary disease in April 2022.
  • The first generic version of twice daily PERFOROMIST, a formoterol fumarate inhalation solution, 20 mcg/2 ml, for the treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, was officially launched by Teva Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries Ltd., in June 2021.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5679
  • Published Date: Feb 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of respiratory disease and growing awareness about the disease are some of the major factors anticipated to drive the growth of the bronchiectasis therapeutics market.

The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2024-2036.

The major players in the market are Zydus Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Insmed Inc., Reddy’s Laboratories Ltd, and others.

The online pharmacy segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying